Playback speed
10 seconds
LARA Trial: Preliminary Efficacy of Pembro + Lenvatinib in Recurrent Clear Cell Gynecological Cancer
By
Insights from 2023 ESMO Asia Annual Meeting
FEATURING
Natalie Ngoi
By
Insights from 2023 ESMO Asia Annual Meeting
FEATURING
Natalie Ngoi
160 views
February 13, 2024
Login to view comments.
Click here to Login